Skip to main content
Clinical Trials/NCT06401265
NCT06401265
Completed
Not Applicable

Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation1 site in 1 country8,000 target enrollmentJanuary 1, 2018
ConditionsUterine Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Uterine Cancer
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Enrollment
8000
Locations
1
Primary Endpoint
It is a retrospective and questionnaire-based study.
Status
Completed
Last Updated
last year

Overview

Brief Summary

Among urothelial cancers, upper urinary tract urothelial cancers, including renal pelvis and ureteral cancers have a higher incidence rate in Taiwan than Western countries. In particular, the proportion of female patients is similar to that of males. This situation is significantly different from that in foreign countries. The cause is currently uncertain.In the past, the arsenic contamination of groundwater made blackfoot disease become common and malignant in areas. Now, the number of kidney dialysis patients in Taiwan is increasing; and according to statistics, there is a significantly higher incidence of urothelial cancer among kidney dialysis patients. This may be caused by the use of traditional Chinese medicine or other unknown reasons.

Registry
clinicaltrials.gov
Start Date
January 1, 2018
End Date
September 5, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Case study of upper urinary tract urothelial cancer surgery

Exclusion Criteria

  • Cases of surgery for non-upper urinary tract urothelial cancer

Outcomes

Primary Outcomes

It is a retrospective and questionnaire-based study.

Time Frame: Patients with urothelial carcinoma of the upper urinary tract from January 2008 to December 2019.

Study Sites (1)

Loading locations...

Similar Trials